HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pituicytoma: ultrastructural evidence of a possible origin from folliculo-stellate cells of the adenohypophysis.

Abstract
Pituicytoma is a rare neoplasm occurring in the sellar and suprasellar regions. The tumor is currently considered to arise from the pituicyte, a specialized glial cell of the posterior lobe and the stalk of the pituitary gland. The authors describe a case of pituicytoma, focusing on the ultrastructural features. The patient was a 79-year-old woman with hypopituitarism and visual disturbances. Immunohistochemically, the tumor showed strong and diffuse positivity for vimentin, and EMA and GFAP were focally detectable. Ultrastructurally, the lesion was composed of elongated cells containing in the Golgi area aggregates of intermediate filaments in a concentric pathway (fibrous body), and secretory granules. These features intermediate between a pituicytoma and a pituitary adenoma suggest that "pituicytomas" may also arise from the specialized stromal folliculo-stellate cells of the adenohypophysis, which are able to differentiate into endocrine cells.
AuthorsG Cenacchi, P Giovenali, C Castrioto, F Giangaspero
JournalUltrastructural pathology (Ultrastruct Pathol) 2001 Jul-Aug Vol. 25 Issue 4 Pg. 309-12 ISSN: 0191-3123 [Print] England
PMID11577776 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glial Fibrillary Acidic Protein
  • Mucin-1
  • Vimentin
Topics
  • Aged
  • Cell Lineage (physiology)
  • Cell Nucleus (pathology, ultrastructure)
  • Female
  • Glial Fibrillary Acidic Protein (metabolism)
  • Glioma (metabolism, pathology, ultrastructure)
  • Humans
  • Immunohistochemistry
  • Microscopy, Electron
  • Mucin-1 (metabolism)
  • Neuroglia (pathology, ultrastructure)
  • Organelles (pathology, ultrastructure)
  • Pituitary Gland, Posterior (pathology, ultrastructure)
  • Pituitary Neoplasms (metabolism, pathology, ultrastructure)
  • Secretory Vesicles (ultrastructure)
  • Vimentin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: